B

BioCryst Pharmaceuticals
D

BCRX

7.54500
USD
-0.06
(-0.79%)
مغلق
حجم التداول
116,518
الربح لكل سهم
0
العائد الربحي
-
P/E
-151
حجم السوق
1,871,454,715
أصول ذات صلة المقالات

العنوان: BioCryst Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.